Intellia Therapeutics, Inc.
NTLA
$11.91
$0.080.68%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -106.63M | -96.23M | -95.79M | -101.32M | -101.26M |
| Total Depreciation and Amortization | 2.08M | 2.20M | 6.02M | 4.94M | 2.47M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.29M | 13.85M | 19.99M | 15.08M | 19.03M |
| Change in Net Operating Assets | 4.15M | -37.17M | 494.00K | 4.41M | -19.87M |
| Cash from Operations | -83.11M | -117.35M | -69.29M | -76.90M | -99.62M |
| Capital Expenditure | -1.81M | -79.00K | -126.00K | -29.00K | -239.00K |
| Sale of Property, Plant, and Equipment | 90.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -139.85M | 66.39M | 27.66M | -712.00K | 107.15M |
| Cash from Investing | -141.57M | 66.31M | 27.53M | -741.00K | 106.91M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 196.12M | 33.57M | 1.98M | 114.86M | 14.65M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 196.12M | 33.57M | 1.98M | 114.86M | 14.65M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -28.57M | -17.47M | -39.77M | 37.22M | 21.94M |